As part of a group of 41 states that has reached a settlement with Suboxone manufacturer Indivior, Alabama will receive nearly $1.4 million, the office of Attorney General Steve Marshall said today.

The Yellowhammer State’s share of the nationwide $102.5 million comes to $1,392,964.

“Indivior Inc. illegally exploited the market to maintain its monopoly of Suboxone, restricting critical access to this lifesaving drug,” said Marshall. “I will continue to hold drug manufacturers accountable when they break the law and harm our people.”

The complaint, which was filed in 2016, alleged Indivior was using “illegal means to switch the Suboxone market from tablets to film while attempting to destroy the market for tablets, in order to preserve its monopoly on the drug.”

The settlement will now be sent to the Eastern District of Pennsylvania for consideration. It also will require that Indivior “comply with negotiated injunctive terms that include disclosures to the States of all citizen petitions to the FDA, introduction of new products, or if there is a change in corporate control, which will help the States ensure that Indivior Inc. refrains from engaging in the same kind of conduct alleged in the complaint.”

Alabama and Wisconsin led the lawsuit followed by Alaska, Arkansas, California, Colorado, District of Columbia, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Hampshire, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Virginia, Washington, and West Virginia.

Austen Shipley is a staff writer for Yellowhammer News.